US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

First Advantage Corp.

17.66

-0.1700-0.95%

Post-market: 17.660.00000.00%16:05 EDT

Volume:1.78M

Turnover:31.31M

Market Cap:3.07B

PE:-23.80

High:17.93

Open:17.64

Low:16.94

Close:17.83

Loading ...

Overview Company News Filings

Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst

Some May Be Optimistic About First Advantage's (NASDAQ:FA) Earnings

Simply Wall St.

Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference

Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024

First Advantage Price Target Maintained With a $22.00/Share by RBC Capital

Discover US Stocks That May Be Trading Below Estimated Value In November 2024

Simply Wall St.

RBC Upgrades First Advantage to Outperform, Price Target is $22

MT Newswires Live

First Advantage reinstated with an Outperform at RBC Capital

First Advantage Corp (FA) Q3 2024 Earnings Call Highlights: Strategic Acquisition and Strong ...

Why London FA rebrand could help it find next Bukayo Saka or Chloe Kelly

First Advantage Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

Jasper Therapeutics to Participate at Upcoming Investor Conferences

Lexeo Therapeutics reaches FDA alignment on development plan for LX2006

Press Release: Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results

Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions

First Advantage Corp reports results for the quarter - Earnings Summary

First Advantage (FA) Beats Q3 Earnings Estimates

First Advantage: Q3 Earnings Snapshot

Associated Press Finance

First Advantage Q3 Adjusted Earnings, Revenue Decline

MT Newswires Live

First Advantage reports Q3 adjusted EPS 26c, consensus 25c

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FA/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FA\",,,,,undefined,":{"symbol":"FA","market":"US","secType":"STK","nameCN":"First Advantage Corp.","latestPrice":17.66,"timestamp":1746820800000,"preClose":17.83,"halted":0,"volume":1776502,"hourTrading":{"tag":"盘后","latestPrice":17.66,"preClose":17.66,"latestTime":"16:05 EDT","volume":33727,"amount":595618.82,"timestamp":1746821112200},"delay":0,"floatShares":79551380,"shares":173642659,"eps":-0.742168,"marketStatus":"Market Closed","change":-0.17,"latestTime":"05-09 16:00:00 EDT","open":17.64,"high":17.93,"low":16.94,"amount":31314676.905255,"amplitude":0.055524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.742168,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"listingDate":1624420800000,"exchange":"NASDAQ","adjPreClose":17.83,"preHourTrading":{"tag":"盘前","latestPrice":17.38,"preClose":17.83,"latestTime":"09:29 EDT","volume":623,"amount":10857.629671,"timestamp":1746797383017},"postHourTrading":{"tag":"盘后","latestPrice":17.66,"preClose":17.66,"latestTime":"16:05 EDT","volume":33727,"amount":595618.82,"timestamp":1746821112200},"volumeRatio":1.3873216513191566,"impliedVol":0.3663,"impliedVolPercentile":0.768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FA\",,,,,undefined,":{"symbol":"FA","floatShares":79551380,"roa":"-1.23%","roe":"-13.59%","lyrEps":-0.742168,"volumeRatio":1.3873216513191566,"shares":173642659,"dividePrice":0,"high":17.93,"amplitude":0.055524,"preClose":17.83,"low":16.94,"week52Low":12.32,"pbRate":"2.40","psRate":"2.93","week52High":20.79,"institutionHeld":0,"latestPrice":17.66,"eps":-0.742168,"divideRate":0,"volume":1776502,"delay":0,"ttmEps":-0.742168,"open":17.64,"prevYearClose":18.73,"prevWeekClose":14.98,"prevMonthClose":14.1,"prevQuarterClose":14.09,"fiveDayClose":14.98,"twentyDayClose":13.83,"sixtyDayClose":19.69},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FA\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2484771989","title":"Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2484771989","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484771989?lang=en_us&edition=fundamental","pubTime":"2024-11-20 03:47","pubTimestamp":1732045644,"startTime":"0","endTime":"0","summary":"On Monday, Rocket Pharmaceuticals, Inc.  presented long-term safety and efficacy results from the Phase 1 study of RP-A501 in male patients with Danon disease.Danon disease isa rare X-linked dominant genetic disorder that manifests with the clinical triad of cardiomyopathy , skeletal myopathy , and intellectual disability.Also Read: FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides. Danon disease is caused by mutations in the LAMP2 gene, which contains instructions for the production of an enzyme called lysosomal-associated membrane protein-2 . The data showed that RP-A501 was generally well tolerated.All evaluable Danon disease patients demonstrated LAMP2 protein expression at 12 months  and reduction of left ventricular  mass index by ≥10% at 12 months  after treatment.These data were presented at the American Heart Association  Scientific Sessions 2024.Evidence of sustained clinically meaningful improvement was observed in pe","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/3vJwnV.fyXKsx.OAsR1l7A--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/2d742347a4190f9eba3ad8b9cafa0828","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/3vJwnV.fyXKsx.OAsR1l7A--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/2d742347a4190f9eba3ad8b9cafa0828"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rocket-pharmaceuticals-gene-therapy-progress-194724790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","FA","RCKT","BK4539","LU2065732104.USD","PRGS","RCKTW","BK4535","BK4097","BK4130"],"gpt_icon":0},{"id":"2484294333","title":"Some May Be Optimistic About First Advantage's (NASDAQ:FA) Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2484294333","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484294333?lang=en_us&edition=fundamental","pubTime":"2024-11-19 19:18","pubTimestamp":1732015136,"startTime":"0","endTime":"0","summary":"First Advantage Corporation's  earnings announcement last week didn't impress shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced by some positive underlying factors.NasdaqGS:FA Earnings and Revenue History November 19th 2024. One key financial ratio used to measure how well a company converts its profit to free cash flow  is the accrual ratio. To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. This ratio tells us how much of a company's profit is not backed by free cashflow.If First Advantage's EPS can grow over time then that drastically improves the chances of the share price moving in the same direction. But","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gTXxAripYKuyYIBo3IPy5A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d43968f232f0a675f3e0acde96f52fef","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gTXxAripYKuyYIBo3IPy5A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d43968f232f0a675f3e0acde96f52fef"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/may-optimistic-first-advantages-nasdaq-111856982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","FA","NDAQ"],"gpt_icon":0},{"id":"2484677041","title":"Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677041","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484677041?lang=en_us&edition=fundamental","pubTime":"2024-11-19 00:00","pubTimestamp":1731945600,"startTime":"0","endTime":"0","summary":"All six evaluable Phase 1 patients with Danon disease are alive and transplant-free up to age 25 years. RP-A501 demonstrated safety and meaningful efficacy; all evaluable patients show cardiac LAMP2 expression and ≥10% reduction in LV mass index at 12 months and sustained through most recent follow up . First patient treated shows preliminary evidence of robust protein expression in heart on five-year biopsy. All evaluable patients had reductions in NYHA heart failure  and improvements in KCCQ  at 24-54 months. Substantial improvements in troponin  and BNP  observed 24-54 months after treatment. Phase 1 data published in The New England Journal of Medicine. Investor webinar to be held later today at 12:00 p.m. ET. The safety and preliminary efficacy of RP-A501 was evaluated in a single-arm, open-label, multi-center Phase 1 study in male patients with Danon disease. Five patients [pediatric (n=2) and adult/adolescent (n=3)] were treated with the low dose , and 2 adult/adolescent patient","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dEZh2UtCRK9YcuqoU1CxwA--~B/aD00NjU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/54fd333d9749296ca1efcc2def41c367","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dEZh2UtCRK9YcuqoU1CxwA--~B/aD00NjU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/54fd333d9749296ca1efcc2def41c367"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rocket-pharmaceuticals-announces-england-journal-160000616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4516","BK4585","BK4139","LU0128525689.USD","LU2236285917.USD","BK4109","BK4535","AFG","BK4117","LU0211328371.USD","FA","BK4107","PKD","LU0310800965.SGD","RCKT","LU0052756011.USD","BK4504","LU1267930490.SGD","DD","LU0310799852.SGD","RCKTW","ACM","LU1267930227.SGD","BK4129","BK4130","LU0211327993.USD","LU2308191902.HKD","BK4588","BK4539"],"gpt_icon":1},{"id":"2484626103","title":"Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2484626103","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484626103?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:00","pubTimestamp":1731931200,"startTime":"0","endTime":"0","summary":"Treatment with nomlabofusp modified gene expression and lipid profiles in addition to increasing frataxin (FXN) levels in study participants with Friedreich’s ataxia (FA)Modeling and simulation predic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/18/2982603/0/en/Larimar-Therapeutics-Presents-Additional-Data-from-Phase-1-Studies-and-Phase-2-Dose-Exploration-Study-Supporting-the-Nomlabofusp-Clinical-Program-at-ICAR-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","FXN","PK","BK4539","BK4218","BK4181","BK4130","FA","BK4535","BK4139"],"gpt_icon":0},{"id":"2483302202","title":"First Advantage Price Target Maintained With a $22.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2483302202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483302202?lang=en_us&edition=fundamental","pubTime":"2024-11-16 01:10","pubTimestamp":1731690600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 15, 2024 12:10 ET (17:10 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FA"],"gpt_icon":0},{"id":"2483118374","title":"Discover US Stocks That May Be Trading Below Estimated Value In November 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483118374","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483118374?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:09","pubTimestamp":1731679754,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates a \"sometimes-bumpy path\" toward economic stability, highlighted by recent fluctuations in major indexes and cautious optimism from Fed Chair Jerome Powell, investors are keenly observing opportunities that may arise amidst these conditions. In such an environment, identifying stocks that appear undervalued can be particularly appealing, as they may offer potential for growth despite broader market uncertainties.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Overview: Zillow Group, Inc. operates real estate brands through mobile applications and websites in the United States, with a market cap of approximately $17.29 billion.Operations: I'm sorry, but the revenue segment details are missing from the provided text. Could you please provide the relevant information on Zillow Group's revenue segments?Zillow Group, trading at US$72, is undervalued based on cash flows with an estimated fair value of US$90.48. Despite reporting a Q3 net ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/v2TYmTZo63my46MElvPZPA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1d405932ab06ff458a2892e2e6f5b19b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/v2TYmTZo63my46MElvPZPA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1d405932ab06ff458a2892e2e6f5b19b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/discover-us-stocks-may-trading-140914130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["Z","DFS","BURL","SABK","FA","LU1878469433.USD","BK4539","LU0106831901.USD","LU1861220207.SGD","BK4088","BK4585","BK4535","BK4079","BK4566","BK4094","BK4130","ZG","BK4211","BK4166","LU1668664300.SGD","LU1791807156.HKD","LU2360107671.USD","SDHC","BK4551","BK4548","LU1861217088.USD","BK4588"],"gpt_icon":0},{"id":"2483376066","title":"RBC Upgrades First Advantage to Outperform, Price Target is $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2483376066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483376066?lang=en_us&edition=fundamental","pubTime":"2024-11-15 20:56","pubTimestamp":1731675407,"startTime":"0","endTime":"0","summary":"RBC Upgrades First Advantage to Outperform, Price Target is $22","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FA"],"gpt_icon":0},{"id":"2483340074","title":"First Advantage reinstated with an Outperform at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2483340074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483340074?lang=en_us&edition=fundamental","pubTime":"2024-11-15 18:15","pubTimestamp":1731665731,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Ashish Sabadra reinstated coverage of First Advantage (FA) with an Outperform rating and $22 price target The firm says the com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/first-advantage-reinstated-with-an-outperform-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/first-advantage-reinstated-with-an-outperform-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FA"],"gpt_icon":0},{"id":"2483381107","title":"First Advantage Corp (FA) Q3 2024 Earnings Call Highlights: Strategic Acquisition and Strong ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483381107","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483381107?lang=en_us&edition=fundamental","pubTime":"2024-11-15 01:00","pubTimestamp":1731603617,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.First Advantage Corp  successfully closed a $2.2 billion acquisition of Sterling, doubling its size and enhancing its market position.The company reported strong financial performance with combined revenues of approximately $1.5 billion and adjusted EBITDA of $407 million.The company is an early adopter of AI, utilizing it to reduce reliance on third-party vendors and deliver cost-effective solutions.First Advantage Corp  has expanded its international presence, seeing growth opportunities in EMEA, APAC, Latam, and India.A:  There is no change in our synergy outlook or EPS accretion expectation. The comment about 2025 being more neutral was to clarify the timing of synergy realization and its impact on reported results.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-advantage-corp-fa-q3-170017250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FA"],"gpt_icon":1},{"id":"2483874975","title":"Why London FA rebrand could help it find next Bukayo Saka or Chloe Kelly","url":"https://stock-news.laohu8.com/highlight/detail?id=2483874975","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483874975?lang=en_us&edition=fundamental","pubTime":"2024-11-14 19:29","pubTimestamp":1731583768,"startTime":"0","endTime":"0","summary":"Bukayo Saka is among thousands of current professional football players to have been produced by London  London Football has warned that the game could miss out on the next Bukayo Saka or Chloe Kelly if the capital fails to keep up with the soaring demand to play at grassroots level.The city is one of the biggest producers of footballers in the world, with one study earlier this year placing the number of active male professionals from the London area at more than 2,700.Those numbers put it in the same bracket as football hotbeds like Paris and Sao Paulo and appetite within the M25 for playing at recreational level is only increasing.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/11/GettyImages-2160911851-e1731583318622.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/11/GettyImages-2160911851-e1731583318622.jpg?w=824&h=463&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/why-london-fa-rebrand-could-help-it-find-next-bukayo-saka-or-chloe-kelly/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4539","BK4130","FA","BK4535"],"gpt_icon":0},{"id":"2483822979","title":"First Advantage Third Quarter 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2483822979","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483822979?lang=en_us&edition=fundamental","pubTime":"2024-11-14 18:15","pubTimestamp":1731579306,"startTime":"0","endTime":"0","summary":"NasdaqGS:FA Earnings and Revenue History November 14th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 2.5%. Earnings per share  was also behind analyst expectations.Looking ahead, revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Professional Services industry in the US.The company's shares are down 2.3% from a week ago.We should say that we've discovered 1 warning sign for First Advantage that you should be aware of before investing here.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-advantage-third-quarter-2024-101506310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FA"],"gpt_icon":0},{"id":"2483865599","title":"Jasper Therapeutics to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2483865599","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483865599?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:30","pubTimestamp":1731533400,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., Nov. 13, 2024  -- Jasper Therapeutics, Inc.  , a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit  to address mast cell driven diseases such as chronic spontaneous urticaria , chronic inducible urticaria  and asthma, today announced that it will participate in the following investor conferences:. Jefferies London Healthcare Conference 2024Conference Dates: November 19-21, 2024. Live webcasts of the presentations will be available on the Events & News – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's website for 30 days following the applicable live broadcast.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WLMlCHHH.HRSyIIaqx5dTA--~B/aD0xMzQ7dz0zNzY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a59148bd9dea5711dd37200240d15a0c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WLMlCHHH.HRSyIIaqx5dTA--~B/aD0xMzQ7dz0zNzY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a59148bd9dea5711dd37200240d15a0c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jasper-therapeutics-participate-upcoming-investor-213000485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JSPRW","FA","SCD","BK4130","SCID","BK4535","BK4139","JSPR","BK4539"],"gpt_icon":0},{"id":"2483974002","title":"Lexeo Therapeutics reaches FDA alignment on development plan for LX2006","url":"https://stock-news.laohu8.com/highlight/detail?id=2483974002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483974002?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:56","pubTimestamp":1731502576,"startTime":"0","endTime":"0","summary":"LX2006 for the Treatment of FA Cardiomyopathy: Regulatory Update: Alignment on key elements of accelerated development pathway following a Type C m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-reaches-fda-alignment-on-development-plan-for-lx2006?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-reaches-fda-alignment-on-development-plan-for-lx2006?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4535","BK4130","LXEO","FA","BK4139"],"gpt_icon":0},{"id":"2483013670","title":"Press Release: Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483013670","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483013670?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:30","pubTimestamp":1731501000,"startTime":"0","endTime":"0","summary":"Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval pathway with left-ventricular mass index  and frataxin protein expression as co-primary registrational endpoints. Received RMAT designation for LX2006 for the treatment of Friedreich ataxia  cardiomyopathy, potentially enabling expedited development and increased interaction with the FDA. Completed enrollment of LX2006 SUNRISE-FA Phase 1/2 trial, with four participants treated in cohort 3; total of 16 participants dosed with LX2006 to date across SUNRISE-FA and Weill Cornell trials. Completed enrollment of cohort 1 of LX2020 HEROIC-PKP2 Phase 1/2 trial; initial clinical data including safety and biodistribution on track for late Q1 / early Q2 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARIA","IHC","BK4130","FA","BK4162","LXEO","BK4539","BK4535","BK4139"],"gpt_icon":0},{"id":"2483682620","title":"Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2483682620","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483682620?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:01","pubTimestamp":1731445260,"startTime":"0","endTime":"0","summary":"CRANBURY, N.J., November 12, 2024----Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the company will be presenting new data on the results of the RP-A501 Phase 1 trial to treat patients with Danon disease at the American Heart Association’s 2024 Late-Breaking Science sessions being held from November 16-18, 2024 in Chicago, Illinois.RP-A501 is Rocket’s investigational gene therapy product for the treatment of Danon disease and the first gene therapy for a cardiovascular condition to demonstrate safety and efficacy in clinical studies. Danon disease is caused by mutations in the LAMP2 gene.The only available treatment option for Danon disease is cardiac transplantation, which is associated wi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Jx8F9uRSgsby66UkM1vrVA--~B/aD00NjU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/21053e75f6724b7b91b0b6ae899b56e0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Jx8F9uRSgsby66UkM1vrVA--~B/aD00NjU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/21053e75f6724b7b91b0b6ae899b56e0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rocket-pharmaceuticals-present-updated-data-210100853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2236285917.USD","LU2308191902.HKD","DD","BK4107","BK4535","BK4139","BK4129","BK4588","RCKT","RCKTW","BK4504","PKD","LU0211327993.USD","FA","BK4539","LU0211328371.USD","LU0052756011.USD","LU0128525689.USD","BK4585","BK4109","LU0310799852.SGD","BK4130","BK4117","LU0310800965.SGD","LU1267930227.SGD","ACM","AFG","LU1267930490.SGD","BK4516"],"gpt_icon":1},{"id":"2482084109","title":"First Advantage Corp reports results for the quarter  - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482084109","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482084109?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:28","pubTimestamp":1731425296,"startTime":"0","endTime":"0","summary":"First Advantage Corp reports results for the quarter  - Earnings SummaryFirst Advantage Corp FA.OQ reported quarterly adjusted earnings of 26 cents per share for the quarter , lower than the same quar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL8N3MJ21Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FA"],"gpt_icon":0},{"id":"2482808202","title":"First Advantage (FA) Beats Q3 Earnings Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2482808202","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482808202?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:10","pubTimestamp":1731417004,"startTime":"0","endTime":"0","summary":"First Advantage  came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4%. A quarter ago, it was expected that this provider of background screening services would post earnings of $0.21 per share when it actually produced earnings of $0.21, delivering no surprise.First Advantage , which belongs to the Zacks Technology Services industry, posted revenues of $199.12 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 2%. This compares to year-ago revenues of $200.36 million. The company has topped consensus revenue estimates two times over the last four quarters.First Advantage shares have added about 12.1% since the beginning of the year versus the S&P 500's gain of 25.8%.While First Advantage has underperformed the market so far this y","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/26ddEdIk.0DefsBmi91u3Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/26ddEdIk.0DefsBmi91u3Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-advantage-fa-beats-q3-131004982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FA"],"gpt_icon":0},{"id":"2482705398","title":"First Advantage: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2482705398","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482705398?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:05","pubTimestamp":1731413108,"startTime":"0","endTime":"0","summary":"ATLANTA  — ATLANTA  — First Advantage Corp.  on Tuesday reported a loss of $8.9 million in its third quarter.The Atlanta-based company said it had a loss of 6 cents per share. Earnings, adjusted for one-time gains and costs, came to 26 cents per share.The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 25 cents per share.The provider of background screening services posted revenue of $199.1 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $203.2 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-advantage-q3-earnings-snapshot-120508347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FA"],"gpt_icon":0},{"id":"2482955708","title":"First Advantage Q3 Adjusted Earnings, Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2482955708","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482955708?lang=en_us&edition=fundamental","pubTime":"2024-11-12 19:58","pubTimestamp":1731412681,"startTime":"0","endTime":"0","summary":"First Advantage  reported Q3 adjusted earnings Tuesday of $0.26 per diluted share, down from $0.28 a year earlier.Analysts polled by Capital IQ expected $0.25.Revenue for the quarter ended Sept. 30 was $199.1 million, compared with $200.4 million a year earlier.Analysts polled by Capital IQ expected $204.3 million.The company reiterated its standalone 2024 guidance of $0.88 to $0.98 in adjusted EPS on revenue of $750 million to $800 million. Analysts polled by Capital IQ expected $0.92 in adjusted EPS on revenue of $771.6 million.Including its acquisition of Sterling Check, which closed on Oct. 31, First Advantage estimates 2024 adjusted EPS of $0.83 to $0.95 on revenue of $858 million to $918 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FA"],"gpt_icon":0},{"id":"2482877701","title":"First Advantage reports Q3 adjusted EPS 26c, consensus 25c","url":"https://stock-news.laohu8.com/highlight/detail?id=2482877701","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482877701?lang=en_us&edition=fundamental","pubTime":"2024-11-12 19:36","pubTimestamp":1731411386,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $199.1M, consensus $204.3M. “We were thrilled to have closed on the acquisition of Sterling on October 31,” said CEO Scott Stapl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/first-advantage-reports-q3-adjusted-eps-26c-consensus-25c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/first-advantage-reports-q3-adjusted-eps-26c-consensus-25c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FA"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":143,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"FA","fiscalQuarterEnding":"2025/03","expectedEps":0.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":0.14},{"market":"US","date":"2025-02-27","symbol":"FA","fiscalQuarterEnding":"2024/12","expectedEps":0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.13},{"market":"US","date":"2024-11-12","symbol":"FA","fiscalQuarterEnding":"2024/09","expectedEps":0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":0.21},{"market":"US","date":"2024-08-08","symbol":"FA","fiscalQuarterEnding":"2024/06","expectedEps":0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":0.18},{"market":"US","date":"2024-05-09","symbol":"FA","fiscalQuarterEnding":"2024/03","expectedEps":0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FA\",market:\"US\",,,undefined,":[{"executeDate":"2023-08-18","recordDate":"2023-08-21","paymentDate":"2023-08-31","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.3,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3,"analysts":10,"updateTime":1744344000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FA","date":"2025-05-09","current":-20.840532,"percent":0.246269,"low":-676.959328,"twenty":-62.259066,"median":39.498203,"eighty":73.556046,"high":704.194102,"avg":25.892748,"sd":251.113251,"marketCap":3096048609},"quantilePoints":[{"date":"2021-06-25","current":-69.598825,"twenty":-67.156035,"median":-65.514401,"eighty":-0.000033,"marketCap":3136610250},{"date":"2021-07-02","current":-67.835112,"twenty":-69.001876,"median":-67.665525,"eighty":-52.411527,"marketCap":3057125000},{"date":"2021-07-09","current":-67.529854,"twenty":-68.242123,"median":-67.037596,"eighty":-65.060656,"marketCap":3043367937},{"date":"2021-07-16","current":-63.731088,"twenty":-67.814762,"median":-65.766141,"eighty":-64.857151,"marketCap":2872168937},{"date":"2021-07-23","current":-64.273769,"twenty":-67.740143,"median":-65.749183,"eighty":-64.558676,"marketCap":2896625937},{"date":"2021-07-30","current":-66.512327,"twenty":-67.597689,"median":-65.514401,"eighty":-64.294119,"marketCap":2997511062},{"date":"2021-08-06","current":-62.442221,"twenty":-67.529854,"median":-65.138666,"eighty":-63.751438,"marketCap":2814083562},{"date":"2021-08-13","current":-146.718947,"twenty":-67.597689,"median":-65.189543,"eighty":-63.731088,"marketCap":3657850062},{"date":"2021-08-20","current":-146.780259,"twenty":-69.151113,"median":-65.623312,"eighty":-63.751438,"marketCap":3659378625},{"date":"2021-08-27","current":-143.775984,"twenty":-140.869809,"median":-66.512327,"eighty":-64.070263,"marketCap":3584479062},{"date":"2021-09-03","current":-142.856308,"twenty":-141.458401,"median":-66.664957,"eighty":-64.273769,"marketCap":3561550625},{"date":"2021-09-10","current":-147.945181,"twenty":-142.488438,"median":-67.343308,"eighty":-64.287336,"marketCap":3688421312},{"date":"2021-09-17","current":-136.418578,"twenty":-142.807259,"median":-67.699442,"eighty":-64.375521,"marketCap":3401051562},{"date":"2021-09-24","current":-125.689027,"twenty":-142.488438,"median":-68.343875,"eighty":-64.531542,"marketCap":3133553125},{"date":"2021-10-01","current":-125.259845,"twenty":-141.899846,"median":-72.31223,"eighty":-64.775748,"marketCap":3122853187},{"date":"2021-10-08","current":-128.99986,"twenty":-141.495188,"median":-120.170972,"eighty":-65.033522,"marketCap":3216095500},{"date":"2021-10-15","current":-126.424767,"twenty":-141.213154,"median":-125.137221,"eighty":-65.053873,"marketCap":3151895875},{"date":"2021-10-22","current":-131.820199,"twenty":-140.808497,"median":-125.903618,"eighty":-65.06744,"marketCap":3286409375},{"date":"2021-10-29","current":-114.652917,"twenty":-140.56325,"median":-126.118209,"eighty":-65.128491,"marketCap":2858411875},{"date":"2021-11-05","current":-129.061171,"twenty":-139.962395,"median":-125.474436,"eighty":-65.311646,"marketCap":3217624062},{"date":"2021-11-12","current":-589.248945,"twenty":-141.495188,"median":-126.424767,"eighty":-65.502641,"marketCap":3060559021},{"date":"2021-11-19","current":-544.805094,"twenty":-143.260965,"median":-127.191164,"eighty":-65.60153,"marketCap":2829717656},{"date":"2021-11-26","current":-527.145285,"twenty":-144.070281,"median":-127.405755,"eighty":-65.739007,"marketCap":2737992611},{"date":"2021-12-03","current":-499.478252,"twenty":-146.436913,"median":-127.834937,"eighty":-65.915378,"marketCap":2594290039},{"date":"2021-12-10","current":-502.127223,"twenty":-147.932919,"median":-128.63199,"eighty":-66.518929,"marketCap":2608048796},{"date":"2021-12-17","current":-500.066912,"twenty":-497.005879,"median":-128.815924,"eighty":-66.559086,"marketCap":2597347541},{"date":"2021-12-23","current":-534.503539,"twenty":-499.772582,"median":-129.061171,"eighty":-66.61408,"marketCap":2776211380},{"date":"2021-12-31","current":-560.404591,"twenty":-511.545787,"median":-130.318061,"eighty":-66.715833,"marketCap":2910741447},{"date":"2022-01-07","current":-529.794256,"twenty":-515.66641,"median":-131.820199,"eighty":-67.156761,"marketCap":2751751368},{"date":"2022-01-14","current":-520.081362,"twenty":-525.379304,"median":-135.80546,"eighty":-67.529854,"marketCap":2701302592},{"date":"2022-01-21","current":-482.112773,"twenty":-523.731055,"median":-137.522189,"eighty":-67.529854,"marketCap":2504093744},{"date":"2022-01-28","current":-481.818443,"twenty":-521.906208,"median":-139.116293,"eighty":-67.665524,"marketCap":2502564994},{"date":"2022-02-04","current":-484.467414,"twenty":-520.375692,"median":-140.77171,"eighty":-67.780844,"marketCap":2516323750},{"date":"2022-02-11","current":-503.304544,"twenty":-517.962184,"median":-141.568762,"eighty":-67.828329,"marketCap":2614163799},{"date":"2022-02-18","current":-482.995764,"twenty":-520.375692,"median":-142.794997,"eighty":-68.649134,"marketCap":2508679997},{"date":"2022-02-25","current":-471.516888,"twenty":-518.491979,"median":-143.65336,"eighty":-69.300351,"marketCap":2449058717},{"date":"2022-03-04","current":-466.513276,"twenty":-516.372802,"median":-144.082543,"eighty":-71.226868,"marketCap":2423069954},{"date":"2022-03-11","current":-464.452965,"twenty":-514.960017,"median":-144.756971,"eighty":-97.716642,"marketCap":2412368699},{"date":"2022-03-18","current":-516.5494,"twenty":-514.960017,"median":-146.780259,"eighty":-115.940463,"marketCap":2682957583},{"date":"2022-03-25","current":186.662864,"twenty":-514.960017,"median":-146.749603,"eighty":-71.226868,"marketCap":2996125630},{"date":"2022-04-01","current":192.761089,"twenty":-514.312491,"median":-144.205166,"eighty":-67.760494,"marketCap":3094008244},{"date":"2022-04-08","current":176.276824,"twenty":-513.664964,"median":-144.051887,"eighty":-66.98039,"marketCap":2829419304},{"date":"2022-04-14","current":177.229672,"twenty":-513.194036,"median":-143.65336,"eighty":-66.525531,"marketCap":2844713462},{"date":"2022-04-22","current":168.939897,"twenty":-512.54651,"median":-142.733685,"eighty":-65.502641,"marketCap":2711654284},{"date":"2022-04-29","current":165.458211,"twenty":-511.722386,"median":-141.476794,"eighty":-65.053873,"marketCap":2655769742},{"date":"2022-05-06","current":164.02856,"twenty":-511.074859,"median":-140.587775,"eighty":-64.375521,"marketCap":2632822422},{"date":"2022-05-13","current":48.465021,"twenty":-509.308879,"median":-139.085638,"eighty":-63.744655,"marketCap":2348275664},{"date":"2022-05-20","current":46.570623,"twenty":-506.659907,"median":-136.418578,"eighty":-63.235891,"marketCap":2256486388},{"date":"2022-05-27","current":46.570623,"twenty":-504.952792,"median":-134.732506,"eighty":-0.000033,"marketCap":2256486388},{"date":"2022-06-03","current":46.286463,"twenty":-504.481864,"median":-131.14577,"eighty":45.882325,"marketCap":2242717996},{"date":"2022-06-10","current":44.234198,"twenty":-503.06908,"median":-130.287406,"eighty":45.857066,"marketCap":2143279613},{"date":"2022-06-17","current":39.845509,"twenty":-502.068357,"median":-129.030516,"eighty":45.623424,"marketCap":1930634455},{"date":"2022-06-24","current":39.877082,"twenty":-501.832893,"median":-128.785269,"eighty":45.49713,"marketCap":1932164276},{"date":"2022-07-01","current":40.697988,"twenty":-501.538563,"median":-128.509366,"eighty":45.433984,"marketCap":1971939629},{"date":"2022-07-08","current":40.508549,"twenty":-500.361242,"median":-127.834937,"eighty":45.383466,"marketCap":1962760702},{"date":"2022-07-15","current":39.498203,"twenty":-499.831448,"median":-127.405755,"eighty":45.092992,"marketCap":1913806421},{"date":"2022-07-22","current":42.592387,"twenty":-499.537118,"median":-127.160508,"eighty":44.392065,"marketCap":2063728906},{"date":"2022-07-29","current":44.297345,"twenty":-499.242787,"median":-126.271488,"eighty":44.272087,"marketCap":2146339255},{"date":"2022-08-05","current":36.021023,"twenty":-498.477529,"median":-125.259845,"eighty":44.39838,"marketCap":2122322658},{"date":"2022-08-12","current":40.78048,"twenty":-498.065467,"median":-124.340169,"eighty":44.272087,"marketCap":2402745074},{"date":"2022-08-19","current":39.298026,"twenty":-497.535673,"median":-121.642453,"eighty":44.265772,"marketCap":2315400387},{"date":"2022-08-26","current":38.10166,"twenty":-497.182477,"median":-118.086373,"eighty":44.240513,"marketCap":2244911692},{"date":"2022-09-02","current":35.942999,"twenty":-496.652682,"median":-116.798827,"eighty":43.678508,"marketCap":2117725569},{"date":"2022-09-09","current":38.517787,"twenty":-496.53495,"median":-72.31223,"eighty":43.520642,"marketCap":2269429499},{"date":"2022-09-16","current":35.604896,"twenty":-496.358352,"median":-68.343875,"eighty":42.958637,"marketCap":2097804851},{"date":"2022-09-23","current":34.798649,"twenty":-496.064022,"median":-67.699442,"eighty":42.535555,"marketCap":2050301600},{"date":"2022-09-30","current":33.368211,"twenty":-495.063299,"median":-67.343308,"eighty":42.497667,"marketCap":1966021639},{"date":"2022-10-07","current":34.330506,"twenty":-493.41505,"median":-66.61408,"eighty":42.289283,"marketCap":2022719067},{"date":"2022-10-14","current":33.472243,"twenty":-492.355462,"median":-66.139234,"eighty":42.112472,"marketCap":1972151090},{"date":"2022-10-21","current":38.179684,"twenty":-490.354017,"median":-65.514401,"eighty":41.840942,"marketCap":2249508781},{"date":"2022-10-28","current":37.451461,"twenty":-487.587314,"median":-65.138666,"eighty":41.676761,"marketCap":2206602619},{"date":"2022-11-04","current":26.580134,"twenty":-485.997931,"median":-65.053873,"eighty":41.619929,"marketCap":1566074914},{"date":"2022-11-11","current":31.176487,"twenty":-485.291539,"median":-64.545109,"eighty":41.468377,"marketCap":1865694530},{"date":"2022-11-18","current":31.735024,"twenty":-484.702878,"median":-64.273769,"eighty":41.127385,"marketCap":1899119025},{"date":"2022-11-25","current":32.979037,"twenty":-484.23195,"median":-63.765005,"eighty":40.925316,"marketCap":1973564490},{"date":"2022-12-02","current":34.654646,"twenty":-483.525558,"median":-63.578459,"eighty":40.875858,"marketCap":2073837975},{"date":"2022-12-09","current":34.273826,"twenty":-482.642568,"median":-63.154489,"eighty":40.844815,"marketCap":2051048547},{"date":"2022-12-16","current":32.775933,"twenty":-482.112773,"median":-31.068498,"eighty":40.806761,"marketCap":1961410129},{"date":"2022-12-23","current":33.029813,"twenty":-481.995041,"median":26.580134,"eighty":40.747483,"marketCap":1976603081},{"date":"2022-12-30","current":33.004425,"twenty":-480.699988,"median":29.373938,"eighty":40.672729,"marketCap":1975083786},{"date":"2023-01-06","current":33.689901,"twenty":-476.22617,"median":31.227263,"eighty":40.571695,"marketCap":2016104756},{"date":"2023-01-13","current":34.070721,"twenty":-475.34318,"median":31.582696,"eighty":40.508549,"marketCap":2038894185},{"date":"2023-01-20","current":33.029813,"twenty":-473.930395,"median":31.696942,"eighty":40.497223,"marketCap":1976603081},{"date":"2023-01-27","current":34.781586,"twenty":-471.92895,"median":31.963516,"eighty":40.327941,"marketCap":2081434451},{"date":"2023-02-03","current":36.330255,"twenty":-471.04596,"median":32.026986,"eighty":40.203102,"marketCap":2174111459},{"date":"2023-02-10","current":34.172274,"twenty":-468.573586,"median":32.344336,"eighty":40.03916,"marketCap":2044971366},{"date":"2023-02-17","current":34.47693,"twenty":-466.807606,"median":32.509358,"eighty":39.902341,"marketCap":2063202908},{"date":"2023-02-24","current":34.273826,"twenty":-466.16008,"median":32.54744,"eighty":39.858138,"marketCap":2051048547},{"date":"2023-03-03","current":31.749088,"twenty":-465.748017,"median":32.522052,"eighty":39.844719,"marketCap":2051118068},{"date":"2023-03-10","current":29.804799,"twenty":-465.630285,"median":32.496664,"eighty":39.788151,"marketCap":1925509253},{"date":"2023-03-17","current":31.268734,"twenty":-465.277089,"median":32.115844,"eighty":39.693957,"marketCap":2020085302},{"date":"2023-03-24","current":31.93208,"twenty":-464.688429,"median":31.988904,"eighty":39.644105,"marketCap":2062940074},{"date":"2023-03-31","current":31.93208,"twenty":-459.684817,"median":31.988904,"eighty":39.553373,"marketCap":2062940074},{"date":"2023-04-06","current":30.056413,"twenty":-456.506051,"median":31.963516,"eighty":39.498203,"marketCap":1941764511},{"date":"2023-04-14","current":29.804799,"twenty":-454.857802,"median":31.93208,"eighty":39.472944,"marketCap":1925509253},{"date":"2023-04-20","current":29.942043,"twenty":-452.385429,"median":31.920643,"eighty":39.435056,"marketCap":1934375757},{"date":"2023-04-28","current":29.252813,"twenty":-448.323673,"median":31.840584,"eighty":39.397168,"marketCap":1889848715},{"date":"2023-05-05","current":27.979963,"twenty":-445.615836,"median":31.760412,"eighty":39.37191,"marketCap":1807617535},{"date":"2023-05-12","current":34.627744,"twenty":-147.945181,"median":31.75475,"eighty":39.340336,"marketCap":1853138367},{"date":"2023-05-19","current":36.321642,"twenty":-147.883869,"median":31.909206,"eighty":39.298026,"marketCap":1943789007},{"date":"2023-05-26","current":35.583731,"twenty":-147.785771,"median":31.93208,"eighty":39.2148,"marketCap":1904298937},{"date":"2023-06-02","current":37.387514,"twenty":-147.172654,"median":31.988904,"eighty":39.130248,"marketCap":2000830219},{"date":"2023-06-09","current":37.578825,"twenty":-146.743472,"median":32.090456,"eighty":39.068806,"marketCap":2011068386},{"date":"2023-06-16","current":38.125426,"twenty":-145.872845,"median":32.344336,"eighty":39.045238,"marketCap":2040320290},{"date":"2023-06-23","current":38.480717,"twenty":-144.867333,"median":32.496664,"eighty":39.00735,"marketCap":2059334027},{"date":"2023-06-30","current":42.033624,"twenty":-144.180641,"median":32.522052,"eighty":39.052531,"marketCap":2249471402},{"date":"2023-07-07","current":40.694451,"twenty":-144.082543,"median":32.572828,"eighty":39.298026,"marketCap":2177804237},{"date":"2023-07-14","current":42.088284,"twenty":-144.082543,"median":32.763238,"eighty":39.498203,"marketCap":2252396592},{"date":"2023-07-21","current":42.935515,"twenty":-144.033493,"median":32.801321,"eighty":39.76947,"marketCap":2297737043},{"date":"2023-07-28","current":41.596343,"twenty":-143.825033,"median":32.877485,"eighty":40.03916,"marketCap":2226069879},{"date":"2023-08-04","current":39.054648,"twenty":-143.579786,"median":32.991731,"eighty":40.327941,"marketCap":2090048526},{"date":"2023-08-11","current":45.395505,"twenty":-142.991194,"median":33.029813,"eighty":40.512933,"marketCap":2227194274},{"date":"2023-08-18","current":44.655683,"twenty":-142.75821,"median":33.080589,"eighty":40.708213,"marketCap":2190897105},{"date":"2023-08-25","current":40.54227,"twenty":-142.243191,"median":33.160148,"eighty":40.708213,"marketCap":1989084847},{"date":"2023-09-01","current":41.282092,"twenty":-141.679123,"median":33.248238,"eighty":40.78924,"marketCap":2025382016},{"date":"2023-09-08","current":39.595297,"twenty":-141.458401,"median":33.35134,"eighty":40.869406,"marketCap":1942624471},{"date":"2023-09-15","current":42.909702,"twenty":-141.127318,"median":33.472243,"eighty":40.869406,"marketCap":2105235787},{"date":"2023-09-22","current":41.311685,"twenty":-140.734923,"median":33.677207,"eighty":40.928085,"marketCap":2026833903},{"date":"2023-09-29","current":41.311685,"twenty":-140.550988,"median":33.784339,"eighty":41.003352,"marketCap":2026833903},{"date":"2023-10-06","current":41.548428,"twenty":-139.680361,"median":33.969169,"eighty":41.027593,"marketCap":2038448997},{"date":"2023-10-13","current":41.725986,"twenty":-139.079506,"median":34.045333,"eighty":41.282092,"marketCap":2047160317},{"date":"2023-10-20","current":40.54227,"twenty":-138.797473,"median":34.121498,"eighty":41.302101,"marketCap":1989084847},{"date":"2023-10-27","current":38.411581,"twenty":-138.6258,"median":34.173366,"eighty":41.295712,"marketCap":1884549001},{"date":"2023-11-03","current":39.21059,"twenty":-136.418578,"median":34.197662,"eighty":41.282092,"marketCap":1923749943},{"date":"2023-11-10","current":46.093814,"twenty":-136.418578,"median":34.273826,"eighty":41.295712,"marketCap":1964794899},{"date":"2023-11-17","current":47.322482,"twenty":-135.192343,"median":34.299214,"eighty":41.350372,"marketCap":2017168097},{"date":"2023-11-24","current":51.5781,"twenty":-134.456603,"median":34.299214,"eighty":41.400092,"marketCap":2198568106},{"date":"2023-12-01","current":52.803719,"twenty":-132.310693,"median":34.340248,"eighty":41.555151,"marketCap":2250811308},{"date":"2023-12-08","current":53.450573,"twenty":-130.741113,"median":34.434538,"eighty":41.676761,"marketCap":2278384109},{"date":"2023-12-15","current":55.22091,"twenty":-130.373242,"median":34.464236,"eighty":41.725986,"marketCap":2353846513},{"date":"2023-12-22","current":54.982595,"twenty":-130.299668,"median":34.600306,"eighty":41.884021,"marketCap":2343688113},{"date":"2023-12-29","current":56.514618,"twenty":-130.287406,"median":34.615807,"eighty":41.980485,"marketCap":2408992116},{"date":"2024-01-05","current":53.246303,"twenty":-130.287406,"median":34.654646,"eighty":42.033624,"marketCap":2269676909},{"date":"2024-01-12","current":53.654842,"twenty":-129.061171,"median":34.781586,"eighty":42.229065,"marketCap":2287091310},{"date":"2024-01-19","current":54.267651,"twenty":-129.012122,"median":34.802811,"eighty":42.424831,"marketCap":2313212911},{"date":"2024-01-26","current":56.174169,"twenty":-128.852711,"median":34.902681,"eighty":42.711712,"marketCap":2394480115},{"date":"2024-02-02","current":56.650798,"twenty":-128.766875,"median":35.073548,"eighty":43.006574,"marketCap":2414796916},{"date":"2024-02-09","current":56.650798,"twenty":-128.754613,"median":35.23857,"eighty":43.678508,"marketCap":2414796916},{"date":"2024-02-16","current":58.216866,"twenty":-128.558415,"median":35.287811,"eighty":44.369013,"marketCap":2481552119},{"date":"2024-02-23","current":58.965855,"twenty":-128.178282,"median":35.370824,"eighty":45.004587,"marketCap":2513478521},{"date":"2024-03-01","current":60.955523,"twenty":-127.883986,"median":35.433415,"eighty":45.380704,"marketCap":2273214322},{"date":"2024-03-08","current":62.551421,"twenty":-127.687789,"median":35.522046,"eighty":45.466766,"marketCap":2332730150},{"date":"2024-03-15","current":62.201102,"twenty":-127.552903,"median":35.578888,"eighty":45.920213,"marketCap":2319665700},{"date":"2024-03-22","current":62.045405,"twenty":-127.38123,"median":35.669916,"eighty":46.095098,"marketCap":2313859278},{"date":"2024-03-28","current":62.473572,"twenty":-127.258607,"median":35.85902,"eighty":46.248575,"marketCap":2329826939},{"date":"2024-04-05","current":59.94349,"twenty":-127.197295,"median":36.021023,"eighty":46.570623,"marketCap":2235472577},{"date":"2024-04-12","current":60.994447,"twenty":-126.890736,"median":36.151063,"eighty":47.312213,"marketCap":2274665928},{"date":"2024-04-19","current":57.841576,"twenty":-126.461554,"median":36.219194,"eighty":47.917463,"marketCap":2157085877},{"date":"2024-04-26","current":64.123991,"twenty":-126.302144,"median":36.287866,"eighty":49.788803,"marketCap":2391376011},{"date":"2024-05-03","current":64.591197,"twenty":-125.946536,"median":36.463158,"eighty":51.925359,"marketCap":2408799516},{"date":"2024-05-10","current":72.955782,"twenty":-125.517354,"median":36.554398,"eighty":53.028415,"marketCap":2368144672},{"date":"2024-05-17","current":73.090841,"twenty":-125.23532,"median":36.758923,"eighty":53.396101,"marketCap":2372528702},{"date":"2024-05-24","current":73.940735,"twenty":-125.174008,"median":37.048337,"eighty":53.586752,"marketCap":2400116245},{"date":"2024-05-31","current":72.062023,"twenty":-124.8184,"median":37.113785,"eighty":53.94082,"marketCap":2339133255},{"date":"2024-06-07","current":73.225035,"twenty":-123.19977,"median":37.387514,"eighty":54.14509,"marketCap":2376884630},{"date":"2024-06-14","current":74.298584,"twenty":-121.826388,"median":37.451461,"eighty":54.267651,"marketCap":2411732052},{"date":"2024-06-21","current":71.25686,"twenty":-121.67924,"median":37.503477,"eighty":55.030258,"marketCap":2312997688},{"date":"2024-06-28","current":69.646536,"twenty":-121.642453,"median":37.578825,"eighty":55.248146,"marketCap":2260726554},{"date":"2024-07-05","current":72.196216,"twenty":-121.642453,"median":37.715475,"eighty":55.391135,"marketCap":2343489183},{"date":"2024-07-12","current":70.988473,"twenty":-118.515555,"median":37.909907,"eighty":55.969899,"marketCap":2304285832},{"date":"2024-07-15","current":71.25686,"twenty":-118.343882,"median":37.967688,"eighty":56.051607,"marketCap":2312997688},{"date":"2024-08-02","current":76.177296,"twenty":-118.172209,"median":37.982658,"eighty":56.133315,"marketCap":2472715042},{"date":"2024-08-09","current":85.000861,"twenty":-117.559092,"median":38.10166,"eighty":56.501,"marketCap":2496645298},{"date":"2024-08-16","current":103.993647,"twenty":-117.166697,"median":38.175904,"eighty":56.548663,"marketCap":2551900115},{"date":"2024-08-23","current":109.8007,"twenty":-115.940463,"median":38.234746,"eighty":56.671225,"marketCap":2694399381},{"date":"2024-08-30","current":111.459858,"twenty":-97.716642,"median":38.405153,"eighty":57.701448,"marketCap":2735113457},{"date":"2024-09-06","current":112.881993,"twenty":-71.769549,"median":38.473244,"eighty":58.145711,"marketCap":2770011236},{"date":"2024-09-13","current":114.244873,"twenty":-69.449588,"median":38.517787,"eighty":58.557315,"marketCap":2803454941},{"date":"2024-09-20","current":117.385422,"twenty":-68.649134,"median":38.644697,"eighty":58.969477,"marketCap":2880520871},{"date":"2024-09-27","current":116.141054,"twenty":-67.828329,"median":38.699843,"eighty":59.94349,"marketCap":2849985314},{"date":"2024-10-04","current":117.029888,"twenty":-67.780844,"median":38.805615,"eighty":60.612989,"marketCap":2871796426},{"date":"2024-10-11","current":115.192963,"twenty":-67.665524,"median":38.863337,"eighty":60.986662,"marketCap":2826720128},{"date":"2024-10-18","current":117.6817,"twenty":-67.529854,"median":38.94479,"eighty":61.516033,"marketCap":2887791242},{"date":"2024-10-25","current":106.719407,"twenty":-67.455235,"median":38.961457,"eighty":61.726225,"marketCap":2618787526},{"date":"2024-10-31","current":110.808046,"twenty":-67.156761,"median":39.037946,"eighty":62.045405,"marketCap":2719118641},{"date":"2024-11-08","current":110.808046,"twenty":-66.715833,"median":39.071963,"eighty":62.278951,"marketCap":2719118641},{"date":"2024-11-15","current":628.179146,"twenty":-66.61408,"median":39.193994,"eighty":62.551421,"marketCap":3081846892},{"date":"2024-11-22","current":652.813623,"twenty":-66.545338,"median":39.319181,"eighty":63.18958,"marketCap":3202703633},{"date":"2024-11-29","current":676.744257,"twenty":-66.518929,"median":39.380028,"eighty":63.669251,"marketCap":3320107325},{"date":"2024-12-06","current":695.747996,"twenty":-65.915378,"median":39.435056,"eighty":64.201859,"marketCap":3413339667},{"date":"2024-12-13","current":687.30189,"twenty":-65.739007,"median":39.54675,"eighty":65.433103,"marketCap":3371903071},{"date":"2024-12-20","current":653.869386,"twenty":-65.557966,"median":39.636129,"eighty":70.478537,"marketCap":3207883208},{"date":"2024-12-27","current":665.482782,"twenty":-65.502641,"median":39.713669,"eighty":71.131613,"marketCap":3264858529},{"date":"2025-01-03","current":648.59057,"twenty":-65.372698,"median":39.844193,"eighty":71.417893,"marketCap":3181985335},{"date":"2025-01-10","current":614.454224,"twenty":-65.169192,"median":39.877082,"eighty":71.874152,"marketCap":3014512423},{"date":"2025-01-17","current":641.552148,"twenty":-65.081007,"median":40.092836,"eighty":72.196216,"marketCap":3147454838},{"date":"2025-01-24","current":648.238649,"twenty":-65.053873,"median":40.281131,"eighty":73.001379,"marketCap":3180258810},{"date":"2025-01-31","current":659.852045,"twenty":-65.053873,"median":40.494392,"eighty":73.135572,"marketCap":3237234131},{"date":"2025-02-07","current":668.298151,"twenty":-65.019955,"median":40.512677,"eighty":73.538153,"marketCap":3278670728},{"date":"2025-02-14","current":704.194102,"twenty":-64.612944,"median":40.54227,"eighty":73.717078,"marketCap":3454776264},{"date":"2025-02-21","current":659.500124,"twenty":-64.504408,"median":40.54227,"eighty":74.137552,"marketCap":3235507606},{"date":"2025-02-28","current":-25.465823,"twenty":-64.341604,"median":40.601372,"eighty":74.495402,"marketCap":2808192701},{"date":"2025-03-07","current":-21.116132,"twenty":-64.280552,"median":40.54227,"eighty":74.334369,"marketCap":2328539239},{"date":"2025-03-14","current":-19.920286,"twenty":-64.273769,"median":40.521574,"eighty":74.227014,"marketCap":2196669655},{"date":"2025-03-21","current":-21.950078,"twenty":-63.866758,"median":40.508549,"eighty":74.137552,"marketCap":2420500923},{"date":"2025-03-28","current":-22.374918,"twenty":-63.737871,"median":40.295927,"eighty":73.97652,"marketCap":2467349328},{"date":"2025-04-04","current":-23.09872,"twenty":-63.731088,"median":40.182296,"eighty":73.869165,"marketCap":2547165129},{"date":"2025-04-11","current":-21.76126,"twenty":-63.486882,"median":39.913747,"eighty":73.743917,"marketCap":2399679410},{"date":"2025-04-17","current":-21.698321,"twenty":-63.385129,"median":39.844851,"eighty":73.717078,"marketCap":2392738905},{"date":"2025-04-25","current":-22.469327,"twenty":-63.235891,"median":39.713669,"eighty":73.636562,"marketCap":2477760085},{"date":"2025-05-02","current":-22.769607,"twenty":-62.727128,"median":39.618689,"eighty":73.582885,"marketCap":2510872849},{"date":"2025-05-09","current":-20.840532,"twenty":-62.259066,"median":39.498203,"eighty":73.556046,"marketCap":3096048609}],"updateTime":1747002375668}}}